Hospital or health organisation · founded 1946

Harbor–UCLA Medical Center

Torrance, United States · harbor-ucla.org

Part of Los Angeles County Department of Health Services

Manage this page

Citations, last 5 years: 38.3k
Works, last 5 years: 3 826
h-index: 540
Scientists listed: 0
Grants since 2016: 283

Grants received

2016–2021 · research · R01

Developmental Nicotine Exposure & Transgenerationally Altered Lung Phenotype

Virender K Rehan · Harbor–UCLA Medical Center · funded by National Institutes of Health

$525.6k

2016–2019 · research · R01

Developmental Nicotine Exposure & Transgenerationally Altered Lung Phenotype

Virender K Rehan · Harbor–UCLA Medical Center · funded by National Institutes of Health

$457.2k

2016–2021 · cooperative agreement · U01

Systems Immunolobiology of Antibiotic-Persistent MRSA Infection

Michael R Yeaman · Harbor–UCLA Medical Center · funded by National Institutes of Health

$2.3MAntimicrobial Resistance in Staphylococcus

2016–2018 · research · R21

Modified neural stem cells for glycosylation-independent treatment of MPS IIIB

Michelina Iacovino · Harbor–UCLA Medical Center · funded by National Institutes of Health

$260.6k

2016–2021 · research · R01

Endothelial invasion by yeast-phase Candida

Scott G Filler · Harbor–UCLA Medical Center · funded by National Institutes of Health

$549.2kAntifungal resistance and susceptibility

2016–2021 · cooperative agreement · U01

Systems Immunolobiology of Antibiotic-Persistent MRSA Infection

Michael R Yeaman · Harbor–UCLA Medical Center · funded by National Institutes of Health

$2MAntimicrobial Resistance in Staphylococcus

2016–2021 · cooperative agreement · U01

Systems Immunolobiology of Antibiotic-Persistent MRSA Infection

Michael R Yeaman · Harbor–UCLA Medical Center · funded by National Institutes of Health

$2MAntimicrobial Resistance in Staphylococcus

2016–2021 · research · R01

Endothelial invasion by yeast-phase Candida

Scott G Filler · Harbor–UCLA Medical Center · funded by National Institutes of Health

$532.6kAntifungal resistance and susceptibility

2016–2021 · research · R01

Endothelial invasion by yeast-phase Candida

Scott G Filler · Harbor–UCLA Medical Center · funded by National Institutes of Health

$641.8kAntifungal resistance and susceptibility

2015–2025 · contract · N01

CCTN - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE - SITES FOR MALE CONTRACEPTIVE RESEARCH

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$301.9k

2015–2020 · research · R33

Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$430.8k

2015–2023 · contract · N01

CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$2.3M

2015–2021 · research · R33

Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$481.5k

2015–2020 · research · R01

Phenotypic effects of brain-directed enzyme therapy for Sanfilippo B syndrome

Patricia I Dickson · Harbor–UCLA Medical Center · funded by National Institutes of Health

$324kLysosomal Storage Disorders Research

2015–2020 · career development · K23

Trajectories of Adherence to Cardiovascular Medications in Patients on Dialysis

Jenny I Shen · Harbor–UCLA Medical Center · funded by National Institutes of Health

$182.4kDialysis and Renal Disease Management

2015–2020 · career development · K23

Trajectories of Adherence to Cardiovascular Medications in Patients on Dialysis

Jenny I Shen · Harbor–UCLA Medical Center · funded by National Institutes of Health

$190.3kDialysis and Renal Disease Management

2015–2020 · research · R01

Phenotypic effects of brain-directed enzyme therapy for Sanfilippo B syndrome

Patricia I Dickson · Harbor–UCLA Medical Center · funded by National Institutes of Health

$310.3kLysosomal Storage Disorders Research

2015–2020 · research · R01

Phenotypic effects of brain-directed enzyme therapy for Sanfilippo B syndrome

Patricia I Dickson · Harbor–UCLA Medical Center · funded by National Institutes of Health

$100kLysosomal Storage Disorders Research

2015–2020 · career development · K23

Trajectories of Adherence to Cardiovascular Medications in Patients on Dialysis

Jenny I Shen · Harbor–UCLA Medical Center · funded by National Institutes of Health

$180.9kDialysis and Renal Disease Management

2015–2024 · contract · N01

CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$2.8M

2015–2020 · career development · K23

Trajectories of Adherence to Cardiovascular Medications in Patients on Dialysis

Jenny I Shen · Harbor–UCLA Medical Center · funded by National Institutes of Health

$190.4kDialysis and Renal Disease Management

2015–2023 · contract · N01

CCTN - MALE SITES - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$3.3M

2015–2020 · research · R01

Phenotypic effects of brain-directed enzyme therapy for Sanfilippo B syndrome

Patricia I Dickson · Harbor–UCLA Medical Center · funded by National Institutes of Health

$310.3kLysosomal Storage Disorders Research

2015–2022 · career development · K23

Trajectories of Adherence to Cardiovascular Medications in Patients on Dialysis

Jenny I Shen · Harbor–UCLA Medical Center · funded by National Institutes of Health

$190.3kDialysis and Renal Disease Management

2015–2020 · research · R33

Arf6 Inhibition as Novel Treatment for Multidrug Resistance Gram Negative Infections

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$457.1k

2014–2020 · contract · N01

CCTN - MALE CONTRACEPTIVE - DMAU 28 DAY STUDY

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$454.1k

2014–2020 · contract · N03

CCTN - CONTRACEPTIVE CLINICAL TRIALS - MALE SITES, NES/TES STUDY

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$332.9k

2014–2023 · contract · N01

CCTN - CONTRACEPTIVE CLINICAL TRIALS - MALE SITES, DMAU

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$82.6k

2014–2024 · contract · N01

CCTN - CONTRACEPTIVE CLINICAL TRIALS - SITES FOR MALE CONTRACEPTIVE STUDIES - DMAU

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$25.9k

2014–2021 · contract · N01

CCTN - CONTRACEPTIVE CLINICAL TRIALS - MALE SITES, DMAU

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$402.8k

2014–2023 · contract · N01

CCTN - CONTRACEPTIVE CLINICAL TRIALS - MALE SITES, DMAU

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$757k

2014–2020 · research · R33

Mitigating Resistance & Virulence in MRSA

Michael R Yeaman · Harbor–UCLA Medical Center · funded by National Institutes of Health

$393.7k

2014–2020 · research · R01

Hormonal Mechanisms of Sleep Restriction

Peter Yiwen Liu · Harbor–UCLA Medical Center · funded by National Institutes of Health

$415.9k

2013–2020 · contract · N01

CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - MALE

Christina Wang · Harbor–UCLA Medical Center · funded by National Institutes of Health

$51.5k

2006–2020 · research · R01

Novel Toxins and Receptors in Mucormycosis Pathogenesis

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$394.2kAntifungal resistance and susceptibility

2006–2026 · research · R01

Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$554.8kAntifungal resistance and susceptibility

2006–2026 · research · R01

Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$554.8kAntifungal resistance and susceptibility

2006–2026 · research · R01

Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$554.8kAntifungal resistance and susceptibility

2006–2021 · research · R01

Novel Toxins and Receptors in Mucormycosis Pathogenesis

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$394.2kAntifungal resistance and susceptibility

2006–2026 · research · R01

Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment

Ashraf S. Ibrahim · Harbor–UCLA Medical Center · funded by National Institutes of Health

$554.8kAntifungal resistance and susceptibility